Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?
Agnieszka Wesołek-LeszczyńskaKatarzyna PastusiakPaweł BogdańskiMonika SzulińskaPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2024)
Considering today's knowledge about FAM19A5, we cannot consider this protein as a biomarker of the metabolic syndrome. According to current knowledge, FAM19A5 cannot be considered a marker of metabolic disorders because the results of studies conducted in this area are unclear.